2024/09/20 21:26:47 | |
---|---|
Price | |
47.15 EUR | |
Difference | 1.86% (0.86) |
ISIN | FI0009014377 |
Symbol | ORNBV |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,624 EUR |
Benchmark | OMX HELSINKI 25 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 46.88 EUR |
High | 47.51 EUR |
Low | 46.88 EUR |
Close (prev. day) | 46.29 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
Related Futures | 31 |
Related Options | - |
Date | Headline | Download | |
2024/09/11 | Global Equity Ratings | ||
2024/09/05 | Global Equity Ratings | ||
2024/08/12 | Global Equity Ratings | ||
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings |
2024/09/20 21:26:47 | |
---|---|
Price | |
47.15 EUR | |
Difference | 1.86% (0.86) |
ISIN | FI0009014377 |
Symbol | ORNBV |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 6,624 EUR |
Benchmark | OMX HELSINKI 25 |
Bid (Bid size) | - (0) |
Ask (Ask size) | - (0) |
Open | 46.88 EUR |
High | 47.51 EUR |
Low | 46.88 EUR |
Close (prev. day) | 46.29 EUR |
VWAP | - |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +33.87% | +27.81% | +36.59% |
Perf (abs.) | +11.93 | +10.26 | +12.63 |
Beta | 0.44 | 0.62 | 0.42 |
Volatility | 21.94 | 24.81 | 29.90 |
Ø price 5 days | Ø volume 5 days (pcs.) | 46.72 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 46.89 EUR (29) |
Ø price 100 days | Ø volume 100 days (pcs.) | 41.63 EUR (9) |
Ø price 250 days | Ø volume 250 days (pcs.) | 39.25 EUR (8) |
YTD High | date | 48.78 EUR (2024/09/03) |
YTD Low | date | 31.74 EUR (2024/04/19) |
52 Weeks High | date | 48.78 EUR (2024/09/03) |
52 Weeks Low | date | 31.74 EUR (2024/04/19) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/09/20 | 22:26 | 47.21 EUR | 0.01 | 2 |
Stuttgart | 2024/09/20 | 21:26 | 47.15 EUR | 0.00 | 7 |
Nasdaq Helsinki | 2024/09/20 | 18:00 | 47.19 EUR | 17.05 | 2,093 |
Munich | 2024/09/20 | 08:18 | 47.04 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/09/20 | 17:25 | 47.46 EUR | 0.70 | 2 |
Frankfurt | 2024/09/20 | 21:39 | 47.20 EUR | 0.00 | 3 |
FINRA other OTC Issues | 2024/01/25 | 17:14 | 47.16 USD | 0.06 | 2 |
Euronext Milan MTF Trading After Hours | 2024/07/03 | 18:00 | 42.82 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/09/20 | 17:44 | 47.39 EUR | 0.00 | 1 |
Duesseldorf | 2024/09/20 | 08:10 | 46.84 EUR | 0.00 | 3 |
Berlin | 2024/09/20 | 08:18 | 46.93 EUR | 0.00 | 3 |
ORION OYJ |
- - |
Orionintie 1A - 02200 Espoo |
Telefon: +358-10-4261 |
Fax: + |
E-mail: - |
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. It specializes in central nervous system disorders, oncology, and respiratory diseases. The firm's customers are specialist and general practitioners, veterinarians, pharmacies, hospitals, healthcare centers, clinics, and laboratories. The company was founded by Onni Turpeinen, Eemil Tuurala and Wikki Valkama on September 21, 1917 and is headquartered in Espoo, Finland. |
Liisa Hurme | Chairman of Managing Board |
Hao Pan | Member of Executive Committee |
Jani Korhonen | Member of Executive Committee |
Jari Karlson | Member of Executive Committee |
Juhani Kankaanpää | Member of Executive Committee |
Julia Macharey | Member of Executive Committee |
Niclas Lindstedt | Member of Executive Committee |
Olli Huotari | Member of Executive Committee |
Outi Vaarala | Member of Executive Committee |
Satu Ahomäki | Member of Executive Committee |
Virve Laitinen | Member of Executive Committee |
Veli-Matti Johannes Mattila | Chairman of Supervisory Board |
Ari Tapio Lehtoranta | Member of Supervisory Board |
Hilpi Rautelin | Member of Supervisory Board |
Eija Ronkainen | Member of Supervisory Board |
Henrik Stenqvist | Member of Supervisory Board |
Karen Sörensen | Member of Supervisory Board |
Kari Jussi Aho | Member of Supervisory Board |
Maziar Mike Doustdar | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer